Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes

Cell Metabolism

Volumn 22, Issue 2, 2015, Pages 239-252

  Bhatt, Shweta ^a,b   Gupta, Manoj K ^a,b   Khamaisi, Mogher ^a,b   Martinez, Rachael ^a   Gritsenko, Marina A ^c   Wagner, Bridget K ^d   Guye, Patrick ^e   Busskamp, Volker ^a,g   Shirakawa, Jun ^a,b   Wu, Gongxiong ^a   Liew, Chong Wee ^a,b   Clauss, Therese R ^c   Valdez, Ivan ^a,b   El Ouaamari, Abdelfattah ^a,b   Dirice, Ercument ^a,b   Takatani, Tomozumi ^a,b   Keenan, Hillary A ^a,b   Smith, Richard D ^c   Church, George ^a   Weiss, Ron ^e   Wagers, Amy J ^a,f   Qian, Wei Jun ^c   King, George L ^a,b   Kulkarni, Rohit N ^a,b   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e Massachusetts Institute of Technology   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 200; MICRORNA; MIRN200 MICRORNA, HUMAN;

AGED; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRESS; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DOUBLE STRANDED DNA BREAK; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; DIABETES COMPLICATIONS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY;

AGED; CELL CYCLE CHECKPOINTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; NEURONS;

EID: 84938563378     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.07.015     Document Type: Article

References (53)

1. M.V. Bennetzen, D.H. Larsen, J. Bunkenborg, J. Bartek, J. Lukas, and J.S. Andersen Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response Mol. Cell. Proteomics 9 2010 1314 1323
2. D. Branzei, and M. Foiani Regulation of DNA repair throughout the cell cycle Nat. Rev. Mol. Cell Biol. 9 2008 297 308
3. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
4. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
5. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
6. N.A. Calcutt, M.E. Cooper, T.S. Kern, and A.M. Schmidt Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials Nat. Rev. Drug Discov. 8 2009 417 429
7. A. Chamorro-Jorganes, E. Araldi, and Y. Suárez MicroRNAs as pharmacological targets in endothelial cell function and dysfunction Pharmacol. Res. 75 2013 15 27
8. K.J. Chang-Chen, R. Mullur, and E. Bernal-Mizrachi Beta-cell failure as a complication of diabetes Rev. Endocr. Metab. Disord. 9 2008 329 343
9. N. Dephoure, C. Zhou, J. Villén, S.A. Beausoleil, C.E. Bakalarski, S.J. Elledge, and S.P. Gygi A quantitative atlas of mitotic phosphorylation Proc. Natl. Acad. Sci. USA 105 2008 10762 10767
10. D.M. Epstein Special delivery: microRNA-200-containing extracellular vesicles provide metastatic message to distal tumor cells J. Clin. Invest. 124 2014 5107 5108
11. J. Falck, J. Coates, and S.P. Jackson Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage Nature 434 2005 605 611
12. Z.Y. Fang, J.B. Prins, and T.H. Marwick Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr. Rev. 25 2004 543 567
13. J.M. Forbes, and M.E. Cooper Mechanisms of diabetic complications Physiol. Rev. 93 2013 137 188
14. T. Furuta, H. Takemura, Z.Y. Liao, G.J. Aune, C. Redon, O.A. Sedelnikova, D.R. Pilch, E.P. Rogakou, A. Celeste, H.T. Chen, and et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes J. Biol. Chem. 278 2003 20303 20312
15. A. Georgescu Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy World J. Diabetes 2 2011 92 97
16. M. Goldberg, M. Stucki, J. Falck, D. D'Amours, D. Rahman, D. Pappin, J. Bartek, and S.P. Jackson MDC1 is required for the intra-S-phase DNA damage checkpoint Nature 421 2003 952 956
17. E. Harja, D.X. Bu, B.I. Hudson, J.S. Chang, X. Shen, K. Hallam, A.Z. Kalea, Y. Lu, R.H. Rosario, S. Oruganti, and et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice J. Clin. Invest. 118 2008 183 194
18. M.P. Hunter, N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, L. Yu, T. Xiao, J. Schafer, M.L. Lee, T.D. Schmittgen, and et al. Detection of microRNA expression in human peripheral blood microvesicles PLoS ONE 3 2008 e3694
19. M. Kato, N.E. Castro, and R. Natarajan MicroRNAs: potential mediators and biomarkers of diabetic complications Free Radic. Biol. Med. 64 2013 85 94
20. H.A. Keenan, T. Costacou, J.K. Sun, A. Doria, J. Cavellerano, J. Coney, T.J. Orchard, L.P. Aiello, and G.L. King Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study Diabetes Care 30 2007 1995 1997
21. H.A. Keenan, J.K. Sun, J. Levine, A. Doria, L.P. Aiello, G. Eisenbarth, S. Bonner-Weir, and G.L. King Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study Diabetes 59 2010 2846 2853
22. X.Y. Kong, Y.Q. Du, L. Li, J.Q. Liu, G.K. Wang, J.Q. Zhu, X.H. Man, Y.F. Gong, L.N. Xiao, Y.Z. Zheng, and et al. Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis World J. Gastroenterol. 16 2010 4599 4604
23. P. Lacolley, P. Challande, M. Osborne-Pellegrin, and V. Regnault Genetics and pathophysiology of arterial stiffness Cardiovasc. Res. 81 2009 637 648
24. J.H. Lee, and T.T. Paull ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex Science 308 2005 551 554
25. C.P. Lin, Y. Ban, Y.L. Lyu, and L.F. Liu Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks J. Biol. Chem. 284 2009 28084 28092
26. J. Liu, J. Kim, and P. Oberdoerffer Metabolic modulation of chromatin: implications for DNA repair and genomic integrity Front. Genet. 4 2013 182
27. M. Mabed, and M. Shahin Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus Curr. Stem Cell Res. Ther. 7 2012 179 190
28. R. Madonna, A. Görbe, P. Ferdinandy, and R. De Caterina Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells Mol. Biotechnol. 55 2013 169 178
29. R. Maehr, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R.L. Leibel, and D.A. Melton Generation of pluripotent stem cells from patients with type 1 diabetes Proc. Natl. Acad. Sci. USA 106 2009 15768 15773
30. D. Nakada, B.P. Levi, and S.J. Morrison Integrating physiological regulation with stem cell and tissue homeostasis Neuron 70 2011 703 718
31. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, and et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
32. D. Onat, D. Brillon, P.C. Colombo, and A.M. Schmidt Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis Curr. Diab. Rep. 11 2011 193 202
33. L. Park, K.G. Raman, K.J. Lee, Y. Lu, L.J. Ferran Jr., W.S. Chow, D. Stern, and A.M. Schmidt Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat. Med. 4 1998 1025 1031
34. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, M.W. Lensch, C. Cowan, K. Hochedlinger, and G.Q. Daley Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
35. A.D. Polpitiya, W.J. Qian, N. Jaitly, V.A. Petyuk, J.N. Adkins, D.G. Camp 2nd, G.A. Anderson, and R.D. Smith DAnTE: a statistical tool for quantitative analysis of -omics data Bioinformatics 24 2008 1556 1558
36. B.D. Price, and A.D. D'Andrea Chromatin remodeling at DNA double-strand breaks Cell 152 2013 1344 1354
37. C. Rask-Madsen, and G.L. King Vascular complications of diabetes: mechanisms of injury and protective factors Cell Metab. 17 2013 20 33
38. M.A. Reddy, and R. Natarajan Epigenetic mechanisms in diabetic vascular complications Cardiovasc. Res. 90 2011 421 429
39. M.A. Reddy, W. Jin, L. Villeneuve, M. Wang, L. Lanting, I. Todorov, M. Kato, and R. Natarajan Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice Arterioscler. Thromb. Vasc. Biol. 32 2012 721 729
40. K.T. Rigbolt, T.A. Prokhorova, V. Akimov, J. Henningsen, P.T. Johansen, I. Kratchmarova, M. Kassem, M. Mann, J.V. Olsen, and B. Blagoev System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation Sci. Signal. 4 2011 rs3
41. S. Ruiz, A.D. Panopoulos, A. Herrerías, K.D. Bissig, M. Lutz, W.T. Berggren, I.M. Verma, and J.C. Izpisua Belmonte A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity Curr. Biol. 21 2011 45 52
42. C.G. Schalkwijk, and C.D. Stehouwer Vascular complications in diabetes mellitus: the role of endothelial dysfunction Clin. Sci. 109 2005 143 159
43. C.A. Sommer, M. Stadtfeld, G.J. Murphy, K. Hochedlinger, D.N. Kotton, and G. Mostoslavsky Induced pluripotent stem cell generation using a single lentiviral stem cell cassette Stem Cells 27 2009 543 549
44. J.Y. Song, J.W. Lim, H. Kim, and K.H. Kim Role of NF-kappaB and DNA repair protein Ku on apoptosis in pancreatic acinar cells Ann. N Y Acad. Sci. 1010 2003 259 263
45. C. Spycher, E.S. Miller, K. Townsend, L. Pavic, N.A. Morrice, P. Janscak, G.S. Stewart, and M. Stucki Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin J. Cell Biol. 181 2008 227 240
46. G.S. Stewart, B. Wang, C.R. Bignell, A.M. Taylor, and S.J. Elledge MDC1 is a mediator of the mammalian DNA damage checkpoint Nature 421 2003 961 966
47. M. Stucki, J.A. Clapperton, D. Mohammad, M.B. Yaffe, S.J. Smerdon, and S.P. Jackson MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks Cell 123 2005 1213 1226
48. G. Tiscornia, E.L. Vivas, and J.C. Izpisúa Belmonte Diseases in a dish: modeling human genetic disorders using induced pluripotent cells Nat. Med. 17 2011 1570 1576
49. D. Van Hoof, J. Muñoz, S.R. Braam, M.W. Pinkse, R. Linding, A.J. Heck, C.L. Mummery, and J. Krijgsveld Phosphorylation dynamics during early differentiation of human embryonic stem cells Cell Stem Cell 5 2009 214 226
50. L. Vrba, T.J. Jensen, J.C. Garbe, R.L. Heimark, A.E. Cress, S. Dickinson, M.R. Stampfer, and B.W. Futscher Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells PLoS ONE 5 2010 e8697
51. C. Xu, Y. Xu, O. Gursoy-Yuzugullu, and B.D. Price The histone variant macroH2A1.1 is recruited to DSBs through a mechanism involving PARP1 FEBS Lett. 586 2012 3920 3925
52. Y. Xu, M.K. Ayrapetov, C. Xu, O. Gursoy-Yuzugullu, Y. Hu, and B.D. Price Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-strand break repair Mol. Cell 48 2012 723 733
53. K. Zhou, C. Bellenguez, C.C. Spencer, A.J. Bennett, R.L. Coleman, R. Tavendale, S.A. Hawley, L.A. Donnelly, C. Schofield, C.J. Groves, et al. GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group Wellcome Trust Case Control Consortium 2 MAGIC investigators Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes Nat. Genet. 43 2011 117 120